Readings Newsletter
Become a Readings Member to make your shopping experience even easier.
Sign in or sign up for free!
You’re not far away from qualifying for FREE standard shipping within Australia
You’ve qualified for FREE standard shipping within Australia
The cart is loading…
Rabies is a fatal viral disease transmitted by bites from infected animals, affecting the central nervous system. If not treated promptly, rabies is fatal. Post-exposure treatment, which includes vaccines and immunoglobulins, must be administered immediately after a suspected exposure to prevent progression of the infection. A major obstacle to effective treatment is the blood-brain barrier (BBB), which prevents drugs from reaching the brain. FUS (low-intensity focused ultrasound) offers a promising solution by temporarily opening this barrier to allow treatments to reach the brain. Although this technology is still under development, it could revolutionize emergency rabies treatment. However, prevention, including animal vaccination, remains essential. Further research and investment in this technology is needed to improve access to treatment in high-risk areas.
$9.00 standard shipping within Australia
FREE standard shipping within Australia for orders over $100.00
Express & International shipping calculated at checkout
Rabies is a fatal viral disease transmitted by bites from infected animals, affecting the central nervous system. If not treated promptly, rabies is fatal. Post-exposure treatment, which includes vaccines and immunoglobulins, must be administered immediately after a suspected exposure to prevent progression of the infection. A major obstacle to effective treatment is the blood-brain barrier (BBB), which prevents drugs from reaching the brain. FUS (low-intensity focused ultrasound) offers a promising solution by temporarily opening this barrier to allow treatments to reach the brain. Although this technology is still under development, it could revolutionize emergency rabies treatment. However, prevention, including animal vaccination, remains essential. Further research and investment in this technology is needed to improve access to treatment in high-risk areas.